Protagonist Therapeutics Set to Join S&P SmallCap 600

Core Points - Protagonist Therapeutics Inc. will replace Encore Wire Corp. in the S&P SmallCap 600 effective July 3, 2024 [1][3] - The acquisition of Encore Wire by Prysmian SpA is expected to be completed soon, pending final conditions [1] Company Changes - Addition: Protagonist Therapeutics (Ticker: PTGX) in the Health Care sector [3] - Deletion: Encore Wire (Ticker: WIRE) in the Industrials sector [3]